Biomapas Logo
Contact us
a
cropped-favicon-biomapas.png
Contact us
a

Different Affiliate Based Outsourcing Models for Regulatory Affairs

Webinar: Different Affiliate-Based Outsourcing Models for Regulatory Affairs

Often questions arise about the Affiliate-Based Outsourcing (ABO) Models for Regulatory Affairs:
1. How can it fit your specific needs?
2. How can it adapt to your organization and setup?
3. What are its possibilities of adjusting to your portfolio?

The purpose of this webinar is to share insights on the Regulatory Affairs Affiliate-Based Outsourcing Model’s flexibility and practical tips on how it can be tailored to your needs. We will share examples of different scenarios on how the ABO model can be customized to optimize costs and efficiently manage your local regulatory operations.

 

Expanding across Europe?

Make use of our experience. Explore your options in an informal chat with one of our experts.

Let's Talk

This webinar focuses on learning:

  1. What are the options for the Affiliate-Based Outsourcing Model for Regulatory Affairs.
  2. What are the benefits of different models.
  3. What are the common challenges and how to overcome them.
  4. How to select the most beneficial Affiliate-Based Outsourcing Model for you.

Duration: 30 minutes

Speaker: Head of Regulatory Affairs, Olga Bernardova.

Olga Bernardova

Olga Bernardova

Head of Regulatory Affairs

Other content that might interest you:

Webinar: Effective IMPD Writing. The Quality Part

Webinar: Effective IMPD Writing. The Quality Part

Mar 20, 2021

Effective IMPD writing, including the quality part is a vital document that contains information about an investigational medicinal product and it is an essential part of the Clinical Trial Application (CTA), which is required by competent authorities in EU. The...

read more
Pharmacovigilance Opportunities in the MENA Region

Pharmacovigilance Opportunities in the MENA Region

Pharmacovigilance is getting more and more attention in MENA countries thanks to new regulations and steps in the right direction. The MENA region itself holds great promise for the pharmaceutical industry, being potentially hugely profitable. Together these 22...

Pharmacovigilance in the MENA Region

Pharmacovigilance in the MENA Region

This blog focuses on pharmacovigilance (PV) in the MENA Region; the Middle East and North Africa. We do this by comparing the MENA region and Europe and inter-country differences in the MENA region. Local legislation and requirements will be discussed, such as...

Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database The WHO defines pharmacovigilance (PV) as the science and activities related to detecting, assessing, understanding, and preventing adverse effects of a medicinal product or any other possible drug-related problems. A...

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.
Affiliate-Based Outsourcing
CSV For Pharmacovigilance Systems
Early Phase Oncology
Functional Service Provision
M&A Support

Clinical Research

Read more

Regulatory Affairs

Read more

Pharmacovigilance

Read more

Medical Information

Read more